TokenPost·
Summit Says FDA Declined Ivonescimab-Chemotherapy Approval for Some Advanced Lung Cancer Patients
The FDA cited insufficient evidence that the treatment helps patients live longer.
More news
- TokenPostFed Remarks, NVIDIA Earnings and Russia Rules Set Five Events This Week
- TokenPostBitcoin Falls Below $65,000 to $64,928 on Binance Spot Market
- TokenPostOCC Final Rule Moves U.S. Stablecoin Law Into Implementation
- CoinDeskDid prediction markets call the U.S. midterm election?: State of Crypto
- BeInCryptoGoldman Sachs 2027 Economic Outlook For Investors
- BeInCryptoJensen Huang Reportedly Wants Back In As Nvidia CEO. How Will Stock React?